Discover the Power of GIMOTI: Evoke Pharma’s Leading Treatment for Gastroparesis as Domperidone Supply Comes to an End
The Impact of FDA’s Update on Domperidone Supply Gimoti: The Approved Solution for Gastroparesis The recent update from the FDA regarding the expected loss of supply for unapproved Domperidone in early 2025 has sparked concerns among healthcare providers and patients managing gastroparesis. As the only approved drug shown to reduce hospitalizations, emergency room visits, medical…